RxDoctor Payments Data

Billy Walton, DO

Family Medicine · Tupelo, MSNPI 1710944699

Payments from drug & device makers

$999in general payments, 2019–2025

Across 60 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$171
  • Lilly USA, LLC$121
  • Boehringer Ingelheim$84
  • Novartis$65
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$59
  • AstraZeneca$58
  • plus $441 from 14 others

What the payments were for

  • Food & beverage$999100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$999 in reported general payments places this provider in the 55th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$171,990
Medicare patients
376
Services billed
3,909

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin86$90,448
OzempicSemaglutide54$71,074
JanuviaSitagliptin Phosphate54$56,572
FarxigaDapagliflozin Propanediol53$43,553
EliquisApixaban35$31,176
MounjaroTirzepatide13$17,762
TrulicityDulaglutide17$14,694
Tresiba Flextouch U-100Insulin Degludec26$14,356
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$12,381
Breo ElliptaFluticasone/Vilanterol23$9,086
LinzessLinaclotide13$7,077
Gabapentin295$5,742
Novolog FlexpenInsulin Aspart14$4,301
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$3,576
SynthroidLevothyroxine Sodium36$3,349

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$84$90,44886 claims
MerckJanuvia$171$56,57254 claims
AstraZenecaFarxiga$58$43,55353 claims
Lilly USA, LLCMounjaro, Trulicity$121$32,45530 claims
PfizerEliquis$43$31,17635 claims
AbbVieLinzess, Synthroid$29$10,42649 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →